BNET Industries
Market Cap:$3.5M
Last Fiscal Year Sales:$645.8K
- Public
- US
Dow Jones Description
We are a life sciences company focused on the development and commercialization of a novel, enabling, platform technology called pressure cycling technology ("PCT"). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. Our pressure cycling technology uses instrumentation that is capable of cycling pressure between ambient and ultra-high levels (up to 35,000 psi or greater) at controlled temperatures to rapidly and repeatedly control the interactions of bio-molecules. Our pressure-generating instrument is called the Barocycler ® . Our PCT-related consumables product line includes PULSE (Pressure Used to Lyse Samples for Extraction) Tubes as well as application specific ("ProteoSolve") kits. Our Barocycler instrument, together with our consumable products and reagents, make up the PCT Sample Preparation System ("PCT SPS"). We have experienced negative cash flows from operations with respect to our pressure cycling technology business since our inception. As of March 31, 2009, we had cash of approximately $2.1 million. During 2008, we took a number of cost reduction measures, including a comprehensive restructuring program to significantly reduce costs, centralize core operations, and refocus our business strategy in specific areas where our products have found significant market acceptance. ...
President & CEORichard T. Schumacher
Number of Employees 27
Contact Information
321 Manley St
West Bridgewater, Massachusetts 02379-1022
(508) 580-1818
Peer Companies
NAICS Code In-Vitro Diagnostic Substance Manufacturing: 325413
Recent Events
-
Pressure BioSciences Q1 loss narrows - Quick Facts
-
Pressure BioSciences FY08 loss widens - Quick Facts
-
Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of...
-
Pressure BioSciences, Inc. BBII Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter...
News & Analysis
Filter by
pressure biosciences inc. - All News and Analysis
PRESSURE BIOSCIENCES TO DEBUT PCT MICROTUBE ADAPTER KIT.
Pressure BioSciences, Inc. (Nasdaq:PBIO), South Easton, Mass, will unveil and release for sale its PCT MicroTube Adapter Kit patent pending at the 57th Annual Conference of the American Society for Mass Spectrometry ASMS, to be held at the Pennsylvania Convention Center (Philadelphia, PA) from May 31...
6th Annual Taglich Brothers Small Cap Equity Conference
The 6th Annual Taglich BrothersSmall Cap Equity Conference will be held in Manhattan at the New YorkAthletic Club on Tuesday, May 5th, 2009. This conference is aunique opportunity for investors to meet the management teams from thefollowing small and microcap companies: Baldwin Technology Company,...
Pressure BioSciences, Inc. to Present at Taglich Brothers 6th Annual Small Cap Equity Conference
Taglich Brothers, Inc. ispleased to announce that Richard Schumacher, President & Chief ExecutiveOfficer of Pressure BioSciences, Inc. (NASDAQ: PBIO), will bepresenting at our 6thAnnual Small Cap Equity Conference May 5th, 2009. The Conference willtake place at the New York Athletic Club, New York City....
Pressure BioSciences and Battelle Sign Exclusive Protein Analysis Patent License Agreement.(Battelle Memorial Institute)
Pressure BioSciences, Inc. (South Easton, MA) announced that they have entered into an exclusive patent license agreement with the Battelle Memorial Institute ("Battelle"). The licensed technology is described in the patent application filed by Battelle on July 31, 2008 (United States serial number 12/183,219). This application...
Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating In Update Coverage By Dutton Associates
ROSEVILLE, Calif. -- Dutton Associates updates its coverage of Pressure BioSciences (Nasdaq:PBIO) maintaining a Strong Speculative Buy rating and a 12 month target price of $8. The 15-page report by Dutton senior analyst Denise T. Resnik, M.S. is available at www.jmdutton.com as well as from First Call, Bloomberg Professional, Zacks,...
Dutton Associates Announces Investment Opinion: Pressure BioSciences Strong Speculative Buy Rating In Update Coverage By Dutton Associates
ROSEVILLE, Calif. -- Dutton Associates updates its coverage of Pressure BioSciences (Nasdaq: PBIO) maintaining a Strong Speculative Buy rating and a 12-month target price of $8. The 15-page report by Dutton senior analyst Denise T. Resnik, M.S. is available at www.jmdutton.com as well as from First Call, Bloomberg Professional, Zacks,...
5th Annual Taglich Brothers Small Cap Equity Conference
The 5th Annual Taglich BrothersSmall Cap Equity Conference will be held in Manhattan at Le ParkerMeridien Hotel on Tuesday, May 6th, 2008. This conference is aunique opportunity for investors to meet the management teams from thefollowing small and microcap companies: Air Industries Group, Inc.AIRI,...
QualityStocks.net News Pressure BioSciences Inc. (PBIO) Hires Matthew Potter to Join Management Team as the Vice President of Sales - 3/11/08.
M2 PRESSWIRE-12 March 2008-QualityStocks: QualityStocks.net News Pressure BioSciences Inc. PBIO Hires Matthew Potter to Join Management Team as the Vice President of Sales - 3/11/08C1994-2008 M2 COMMUNICATIONS LTD RDATE:11032008 At www.QualityStocks.Net you can sign up for Quality Stock's ...
Progressive Following for Pressure BioSciences, Inc.
M2 PRESSWIRE-11 March 2008-Market Review: Progressive Following for Pressure BioSciences, Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:11032008 Streetinvesting.com has now resumed our progressive review of Pressure BioSciences, Inc. (Nasdaq: PBIO) after it traded unchanged Tuesday, early in the afternoon with no...
QualityStocks.net News Pressure BioSciences, Inc. (PBIO) Announces Relocation to New Corporate Offices 3/10/08.
M2 PRESSWIRE-11 March 2008-QualityStocks: QualityStocks.net News Pressure BioSciences, Inc. PBIO Announces Relocation to New Corporate Offices 3/10/08C1994-2008 M2 COMMUNICATIONS LTD RDATE:10032008 At www.QualityStocks.Net you can sign up for Quality Stock's Daily Newsletter to find out what Small-Cap and...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Richard T. Schumacher | President & CEO |
| David F. Petersen | Senior Vice President |
| Edmund Y. Ting | Senior Vice President, Engineering |
| Mark M. Manak | Senior Vice President |
| Patricia Garrett | Senior Vice President, Technology |
| Alexander Lazarev | Vice President, R & D |
| Kathleen W. Benjamin | Vice President |
| Matthew B. Potter | Vice President, Sales |
| Nathan Lawrence | Vice President, Marketing & Business Dev |
| Richard D'Allessandro | Vice President, Info Technology |
| Richard H. Newhouse | Vice President, Matls Management |
| Ronald D. DiPaolo | Vice President, Manufacturing |
| John Swatosh | Director, Marketing & Director, Sales |
| Jose Q. Lanuza | Director, Sales |
| William R Prather | Senior Vice President, Finance and Business Development |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| R. Wayne Fritzsche | Chair of Board |
| Calvin A Saravis | Board of Directors |
| Francis E. Capitanio | Board of Directors |
| J Donald Payne | Board of Directors |
| P Thomas Vogel | Board of Directors |
Mr. Richard T. Schumacher, the founder of our Company, has served as a director of Pressure BioSciences since the formation of its legacy business, Boston Biomedica, Inc., in 1978. He has served as CEO of Pressure BioSciences since April 2004 and President since September, 2004. He previously served as CEO and Chairman of the Board of Boston Biomedica from 1992 to February, 2003 and as President from 1986 to August 1999. Mr. Schumacher served as the Director of Infectious Disease Services for Clinical Sciences Laboratory, a New England-based medical reference laboratory, from 1986 to 1988. From 1972 to 1985, Mr. Schumacher was employed by the Center for Blood Research, a nonprofit medical research institute associated with Harvard Medical School. Mr. Schumacher received a BS in Zoology from the University of New Hampshire.
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | President & CEO | Current |
| Pressure BioSciences, Inc. | Board of Directors | Current |
| University of New Hampshire | B.S. In Zoology | Former |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Senior Vice President | Current |
Dr. Edmund Ting joined Pressure BioSciences as Senior Vice President of Engineering in April, 2006. Prior to joining the company, Dr. Ting served as the Chief Research Officer of Avure Technologies, a leading worldwide manufacturer of high pressure hydrostatic processing equipment for the food and materials processing industry, Flow International Corporation, a world leader in the ultrahigh pressure waterjet cutting technology market, and the parent company of Avure Technologies. Dr. Ting last held the position of VP of Engineering Research and Development at Flow International Corporation. Dr. Ting was also a research scientist and a group leader at Grumman Aerospace Corporation. Dr. Ting earned a BS degree in mechanical engineering from Northeastern University and a Sc.D. in materials science and engineering from the Massachusetts Institute of Technology.
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Senior Vice President, Engineering | Current |
| Avure Technologies Incorporated | Chief Research Officer | Former |
| Flow International Corporation | Vice President of Engineering Research and Development | Former |
| Northeastern University | Bachelor of Science Degree In Mechanical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Senior Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Senior Vice President, Technology | Current |
Dr. Alexander Lazarev, Ph.D. joined Pressure BioSciences in April, 2006 as Director of Research and Development and was promoted to Vice President of Research and Development in March, 2007. Prior to joining Pressure BioSciences, Dr. Lazarev worked as a Visiting Scientist at the Barnett Institute of Chemical and Biological Analysis at Northeastern University, and served as a Director of New Technology Development at Proteome Systems, Inc., where he was involved in research and development of innovative proteomic analysis applications. Dr. Lazarev previously held senior research positions at Genomic Solutions, Inc. and PhytoChem Technologies, Inc. Most of Dr. Lazarev’s scientific career has been dedicated to development of methods and applications for biochemical analysis. Dr. Lazarev has been elected as an Executive Board member of the MASSEP.org, a non-profit scientific discussion forum dedicated to the promotion and improvement of chromatography and other analytical technologies. Dr. Lazarev earned his undergraduate and graduate degrees at the University of Kazan, Russian Federation.
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Vice President, R & D | Current |
| Pressure BioSciences, Inc. | Director, Research & Development | Former |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Vice President | Current |
Mr. Matthew B. Potter joined PBI as our Vice President of Sales on February 25, 2008. Mr. Potter has worked in many different disciplines that include molecular biology, chromatography, personalized medicine, diagnostics, and biophysics. Prior to joining PBI Mr. Potter was the Vice President of Sales & Marketing at Abcam, Inc. from July 2007 to January 2008. Prior to Abcam, Mr. Potter was the National Sales Manager: Key Accounts Pharmaceutical at Qiagen, Inc. from July 2005 to May 2007 and from January 2000 to July 2005 he was the Director, Sales and Marketing at MicroCal, LLC. Mr. Potter is also a former Treasurer of the New England Scientific Manufacturers Association and has been cited as a co-author and contributor on assorted scientific publications during his tenure working at the Worcester Foundation for Experimental Biology. Mr. Potter holds a BA in Biology from Clark University and an MBA from Assumption College, both located in Worcester, MA.
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Vice President, Sales | Current |
| Assumption College | MBA | Former |
| Clark University | BA In Biology | Former |
Dr. Nathan P. Lawrence, Ph.D. Dr. Lawrence joined Pressure BioSciences Inc. in August, 2005, serving as Director of Research and Development until his promotion to Vice President of Marketing and Business Development in April, 2006. Dr. Lawrence was responsible for the development of protocols based on Pressure Cycling Technology (PCT). From 2004 through 2005, Dr. Lawrence worked for 454 Life Sciences in product development and prior to 454 Life Sciences, Dr. Lawrence was Director of Research and Development for Boston Biomedica, Inc. He was responsible for the development of PCT, as well as the development of nucleic acid-based diagnostic assays. Prior to joining Boston Biomedica, Inc., Dr. Lawrence held several positions with increasing responsibility in Research and Development and manufacturing at Becton Dickinson and Gene Trak Systems. Dr. Lawrence holds a BA from the University of Miami, an M.S. from Southern Connecticut State University, and a Ph.D. from Yale University.
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Vice President, Marketing & Business Dev | Current |
| Pressure BioSciences, Inc. | Director of Research and Development | Former |
| Life Sciences, Inc. | Former | |
| Yale University | Ph.D. | Former |
| Southern Connecticut State University | M.S. | Former |
| University of Miami | BA | Former |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Vice President, Info Technology | Current |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Vice President, Matls Management | Current |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Vice President, Manufacturing | Current |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Director, Marketing & Director, Sales | Current |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Director, Sales | Current |
Mr. R. Wayne Fritzsche has served as a director and Chairman of the Board of Directors of the Company since October 2, 2003. Mr. Fritzsche has served as a member of the Company’s Scientific Advisory Board since 1999. Mr. Fritzsche is the founder of Fritzsche & Associates, Inc., a consulting firm which provides strategic, financial, and scientific consulting to medical companies in the life sciences and healthcare industries, and has served as its President since 1991. Since 2003, Mr. Fritzsche has also served as interim President of Chemokine Pharmaceutical Company, Inc. (formerly PGBP Pharmaceuticals), a small molecule discovery company. Since 2001, Mr. Fritzsche has served as a board member of Opexa Pharmaceuticals, a multiple sclerosis and cell immunology therapy company, and Vascular Sciences, Inc., an extracorporeal, macular degeneration company. He also previously served as a board member of Intelligent Medical Imaging, an automated microscopic imaging company, from 1994 to 1997, Clarion Pharmaceuticals, a drug development company, from 1994 to 1996, Nobex Pharmaceuticals, a drug delivery firm, from 1996 to 2001, Cardio Command, Inc., a transesophageal cardiac monitoring and pacing firm, from 1999 to 2001, and Hesed BioMed, an antisense oligonucleotide and catalytic antibody company, from 2000 to 2002. Mr. Fritzsche holds a BA from Rowan University, and an MBA from the University of San Diego.
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Chair of Board | Current |
| Opexa Pharmaceuticals, Inc. | Board Member | Current |
| Vascular Sciences' | Board Member | Current |
| Cardiocommand, Inc | Board Member | Former |
| University of San Diego | MBA | Former |
| Rowan University | BA | Former |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Board of Directors | Current |
| Boston University School of Medicine | Associate Research Professor | Former |
| Harvard Medical School | Associate Professor | Former |
| Rutgers University | Ph.D. In Immunology | Former |
| Organization | Position | Status |
|---|---|---|
| Pressure BioSciences, Inc. | Board of Directors | Current |
Mr. Payne has been the CEO from the commencement of operations in 2002. He holds an MBA from Rice Univ. and a BBA from Texas A&M and has 23 years of progressively senior management experience, the last 14 in life sciences.
| Organization | Position | Status |
|---|---|---|
| Nanospectra Biosciences Inc | President and CEO | Current |
| Pressure BioSciences, Inc. | Board of Directors | Current |
| Nanospectra Biosciences Inc | Director | Current |
| LifeCell Corporation | Chief Financial Officer | Former |
| LifeCell Corporation | Vice President | Former |
| Diagnostic Products Corporation | Divisional Vice President | Former |
| Diagnostic Products Corporation | General Manager | Former |
| Rice University | MBA | Former |
| Texas A&M University | Bba | Former |
Array
| Organization | Position | Status |
|---|---|---|
| Vogel Associates | President | Current |
| Adipogenix, Inc. | Board of Directors | Current |
| Pressure BioSciences, Inc. | Board of Directors | Current |
| Mosaic Technologies | Chief Executive Officer | Former |
| Instrumentation Laboratory | President | Former |
| Diagnostic Products Corporation | Divisional Vice President | Former |
| Diagnostic Products Corporation | General Manager | Former |
| Mosaic Technologies | Director | Former |
| Wharton Graduate School of the University of Pennsylvania | MBA | Former |
| Wharton Graduate School of the University of Pennsylvania | Bachelor's Degree In Electrical Engineering | Former |
William R. Prather RPh, MD, is a Registered Pharmacist as well as a Board Certified Internist and Geriatrician. Dr. Prather received his BS in Pharmacy (1970) and medical degree (1973) from the University of Missouri. He practiced internal medicine in the Kansas City, MO and Vail, CO areas until leaving Internal Medicine in 1987 to pursue a Fellowship in Geriatric Medicine at Harvard University. He completed this Fellowship in 1989. In 1992 Dr. Prather left the practice of medicine to pursue a career in the financial industry where he has held Senior Healthcare research positions for a variety of investment banks . Dr. Prather co-founded Panacos, Inc. (NASDAQ:PANC), a public pharmaceutical company. Additionally, he has been on the Boards of several public and private companies, including Boston Biomedica Inc. (a public medical diagnostics company), PriMed (a private medical device company), MdBio (a Maryland healthcare venture firm), and sat on the Advisory Board of MDS Capital Management, (a Canadian venture firm).
| Organization | Position | Status |
|---|---|---|
| Pluristem Life Systems, Inc. | Senior Vice President Corporate Development | Current |
| Wall Street Advisor | Managing Director | Current |
| Bristol Investment Group, Inc. | advisor | Current |
| JM Dutton & Associates | Current | |
| Bristol Investment Group, Inc. | Board of Directors | Current |
| Pressure BioSciences, Inc. | Senior Vice President, Finance and Business Development | Current |
| Pressure BioSciences, Inc. | Board Member | Former |
| University of Missouri | MD | Former |
| Harvard Medical School | MD | Former |
| University of Missouri | B.S. In Pharmacy | Former |
| University of Missouri-Kansas City | B.S. in pharmacy | Former |
| University of Missouri | Degree | Former |
Executive News
-
Pluristem Therapeutics to Present at the 8th Israel Life Science Industry (ILSI) BioMed Conference
-
Stanford's Professor John Cooke Joins Pluristem's Scientific Advisory Board
-
Pressure BioSciences, Inc. (PBIO) Chief Executive Officer to Ring The NASDAQ Stock...
-
Pressure Biosciences, Inc. Announces the Release of Its Much Anticipated, Next Generation...
-
Pluristem Therapeutics to Present at the International Society for Stem Cell Research (ISSCR)...
Industry Transcripts by Seeking Alpha
-
BMP Sunstone Corporation Q1 2009 Earnings Call Transcript
on Jun 30, 2009about BJGP
-
Matrixx Initiatives, Inc., F4Q09 (Qtr End 03/31/09) Earnings Call Transcript
on May 12, 2009about MTXX
-
King Pharmaceuticals Inc., Q1 2009 Earnings Call Transcript
on May 11, 2009about KG
-
Flamel Technologies SA Q1 2009 Earnings Call Transcript
on May 11, 2009about FLML
-
Sucampo Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript
on May 08, 2009about SCMP
Glass Door
IndustryTop Rated
- AstraZeneca's Seroquel Research Director Confessed to Sex-for-Studies Affairs 17 votes
- Forest Labs' Lexapro Flap Over JAMA Article Will Likely Be Examined by the Feds 11 votes
- Medarex Execs Got 10% Pay Raise Despite Delivering Nothing 11 votes
- Pfizer District Sales Manager Guilty of Altering Off-Label Celebrex Documents 10 votes
- Gilead Whistleblower Suit: A Bullet Dodged 10 votes
